UnknownPhase 1/2

Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease

40 participantsStarted 2016-09

Plain-language summary

Herein, the investigators study the safety and efficacy of transplanting purified autologous bone marrow-derived stem cells transplanted via the intrathecal route by interventional radiology and the intravenous route.

Who can participate

Age range24 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients age 24-20 years old * Patients with the diagnosis of definite Motor Neuron Disease Exclusion Criteria: * HIV/HBV/HCV * Malignancies * Bleeding * Pneumonia * Renal failure * liver dysfunction * Severe anemia (hb \< 8) * Bone Marrow diseases * Pregnancy and lactation * Acute medical conditions/infections such as respiratory infections * ventilatory support

What they're measuring

Changes in Functional Rating Scale - via questionnaire

Timeframe: 6 months

Trial details

NCT IDNCT03067857

SponsorStem Cells Arabia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01

View on ClinicalTrials.gov More Motor Neuron Disease trials